SPI-62

An OrbiMed-backed startup looks to cut excess corticosteroids with mid-stage tests for its lead drug queued up
Endpoints
Tue, 05/18/21 - 10:55 am
OrbiMed
corticosteroids
SPI-62
startups
Sparrow Pharmaceuticals